MoneyWorks4Me

Cipla - Quaterly Results

29 Jul 2022 Evaluate
A decrease in the sales to Rs. 31571.30 millions was observed for the quarter ended June 2022. The sales stood at Rs. 35106.70 millions during the similar quarter previous year.The Net Profit of the company registered a slight decline of -18.33% to Rs. 6440.00  millions from Rs. 7885.10 millions.Operating Profit reported a sharp decline to 9750.60 millions from 11977.80 millions in the corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202206 202106 % Var 202206 202106 % Var 202203 202103 % Var
Sales 31571.30 35106.70 -10.07 31571.30 35106.70 -10.07 130917.90 113027.10 15.83
Other Income 1176.80 796.60 47.73 1176.80 796.60 47.73 6667.00 2302.80 189.52
PBIDT 9750.60 11977.80 -18.59 9750.60 11977.80 -18.59 40331.70 32976.90 22.30
Interest 22.10 80.00 -72.38 22.10 80.00 -72.38 269.30 450.70 -40.25
PBDT 9728.50 11897.80 -18.23 9728.50 11897.80 -18.23 40062.40 32526.20 23.17
Depreciation 1074.60 1139.70 -5.71 1074.60 1139.70 -5.71 4600.10 4686.20 -1.84
PBT 8653.90 10758.10 -19.56 8653.90 10758.10 -19.56 35462.30 27840.00 27.38
TAX 2213.90 2873.00 -22.94 2213.90 2873.00 -22.94 8568.40 7393.50 15.89
Deferred Tax -112.50 -89.30 25.98 -112.50 -89.30 25.98 -304.00 -169.20 79.67
PAT 6440.00 7885.10 -18.33 6440.00 7885.10 -18.33 26893.90 20446.50 31.53
Equity 1613.80 1613.20 0.04 1613.80 1613.20 0.04 1613.60 1612.90 0.04
PBIDTM(%) 30.88 34.12 -9.48 30.88 34.12 -9.48 30.81 29.18 5.59
Peers
Company Name CMP
Sun Pharma. Inds. 1840.00
Dr. Reddys Labs. 1222.50
Cipla 1388.90
Lupin 2061.85
Zydus Lifesciences 1212.00
View more..